University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 4 of 14
A Cohort Study of the Intestinal Microbiota of Premature Infants
NCT03717584
An Examination of Infants' Microbiome, Nutrition, and Development Study.
NCT03229863
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
NCT02754037
Lipidome and Microbiome Profile of Acne
NCT02713607
Evaluation of California's Armed and Prohibited Persons System
NCT02318732
Infant Microbiota and Probiotic Intake Study
NCT02457338
Determine How Consumption of Dairy Fat Fractions Rich in Phospholipids and Proteins Influence Inflammation in the Fed State-Phase 1
NCT01811329
Determine How Consumption of Dairy Fat as Cheese Influences Inflammation-Phase 2
NCT01803633
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
NCT01736059
Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study
NCT01817127
Brief Intervention for Alcohol Use Among Injured Patients
NCT00278785
Image-Guided Herniorrhaphy Study
NCT07267494
Sham-Controlled Rapid-Acting Neuromodulation for Depression
NCT07487454
REVIVE Prospective Registry Cohort Study
NCT07429890
Pain Perception During Intra-Articular Knee Joint Injection: What is the Effect of Needle Gauge and the Use of Ethyl Chloride?
NCT06865170
Local Antibiotic Concentrations With Tissue Expanders in Breast Reconstruction
NCT07339215
Comparison of FNB to EUS-CNB for Pancreatic Lesions
NCT07240818
Improving Caregiver Engagement in Early Interventions
NCT07500363
PET-Enabled Dual-Energy CT in Multiple Myeloma
NCT07646873
Goji Berry and Vasomotor Symptoms Pilot Study
NCT07660315
Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing
NCT07384767
Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants
NCT04614714
Using an AI Mobile Application to Promote Healthy Eating
NCT07108452
ctDNA-Informed Management of Early-Stage Rectal Cancer
NCT07209215
Evaluation of the Antioxidant and Anti-Inflammatory Capacities of the 'Rosy Red Valencia' and 'Olinda Valencia' Sweet Orange Varieties in Healthy Subjects
NCT06944210
Comparing Front-of-package Nutrient Labels
NCT06903403
Assessing the Impact of Front-of-package Nutrient Labels
NCT06673706
Climate Labels for Restaurant Menus Pilot
NCT06651060
Effect of Added-sugar Menu Labels
NCT06666725
Fiber Effectively Educates & Directs the Microbiome Study
NCT06395324
Virtual Reality (VR) for Prone Pain Procedures
NCT05615675
Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study
NCT06125145
Feasibility of Internet Group CBT-I for Gyn Oncology Patients
NCT06060158
High in Front-of-package Label Pretest
NCT06227507
Menu Label Noticeability
NCT06204913
Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements
NCT05637814
Limited English Proficiency Virtual Family-Centered Rounds
NCT05917899
Reducing Inappropriate Medication Use for BPSD
NCT06040502
The Influence of Daily Grapes Intake on Sarcopenia in Postmenopausal Women
NCT05863507
Healthy Unique Lipids From Almonds
NCT05782218
Neonatal Intensive Care Unit Virtual Family-Centered Rounds
NCT05762835
Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer
NCT05625217
IUD Placement Without Sounding
NCT05700812
Qigong for Post Acute Sequelae of COVID-19 Infection
NCT05675995
Nurse-To-Family Telehealth
NCT05593900
Exercise-induced Changes in Exosomes
NCT05616234
Evaluation of a Beverage Media Campaign and Added-sugar Warning Labels
NCT05563181
Can Exposure to Inclusive Virtual Art Decrease Pain and Social Disconnection Among Individuals Living With Chronic Pain?
NCT05310747
Aesthetic Outcome of Layered Closure vs. Layered Closure Followed by 2-Octyl Cyanoacrylate
NCT05449457
Effects of Vitamin C Enriched Hydrolyzed Collagen, PrimaColl™, Whey Protein, or Placebo on Collagen Synthesis
NCT05427279
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, Davis pipeline card: 657 registered trials from official public datasets.Report a data error.